Get the latest Science News and Discoveries

Existing drug shows promise as treatment for rare genetic disorder - EurekAlert


A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1). Researchers identified the treatment based on their discovery that the syndrome is linked to elevated levels of interferon-gamma (IFN-gamma), a protein involved in immune system responses, providing new insights into the role of IFN-gamma in autoimmunity. The study, led by researchers at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases, was published today in the New England Journal of Medicine. 

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Treatment

Treatment

Photo of Promise

Promise

Photo of Existing drug shows

Existing drug shows

Related news:

News photo

A novel ‘senolytic’ strategy for treating agi - EurekAlert

News photo

Slugs and snails love the city, unlike other animals - EurekAlert

News photo

Smartphone use may help adolescents feel better - at least in the moment, finds real-time survey of US teens - EurekAlert